ZA941262B - PH-triggered osmotic bursting delivery devices - Google Patents

PH-triggered osmotic bursting delivery devices

Info

Publication number
ZA941262B
ZA941262B ZA941262A ZA941262A ZA941262B ZA 941262 B ZA941262 B ZA 941262B ZA 941262 A ZA941262 A ZA 941262A ZA 941262 A ZA941262 A ZA 941262A ZA 941262 B ZA941262 B ZA 941262B
Authority
ZA
South Africa
Prior art keywords
beneficial agent
osmotic bursting
osmagent
semipermeable membrane
delivery devices
Prior art date
Application number
ZA941262A
Other languages
English (en)
Inventor
Scott M Herbig
Kelly L Smith
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of ZA941262B publication Critical patent/ZA941262B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • External Artificial Organs (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Detergent Compositions (AREA)
ZA941262A 1993-02-25 1994-02-24 PH-triggered osmotic bursting delivery devices ZA941262B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/023,227 US5358502A (en) 1993-02-25 1993-02-25 PH-triggered osmotic bursting delivery devices

Publications (1)

Publication Number Publication Date
ZA941262B true ZA941262B (en) 1995-08-24

Family

ID=21813831

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA941262A ZA941262B (en) 1993-02-25 1994-02-24 PH-triggered osmotic bursting delivery devices

Country Status (19)

Country Link
US (2) US5358502A (ja)
EP (1) EP0612520B1 (ja)
JP (1) JP2862222B2 (ja)
CN (1) CN1098286A (ja)
AT (1) ATE202927T1 (ja)
AU (1) AU660386B2 (ja)
CA (1) CA2116288C (ja)
DE (1) DE69427664T2 (ja)
DK (1) DK0612520T3 (ja)
ES (1) ES2157953T3 (ja)
FI (1) FI113941B (ja)
GR (1) GR3036497T3 (ja)
IL (1) IL108691A0 (ja)
MX (1) MX9401396A (ja)
NO (1) NO312123B1 (ja)
NZ (1) NZ250967A (ja)
PT (1) PT612520E (ja)
TW (1) TW283641B (ja)
ZA (1) ZA941262B (ja)

Families Citing this family (71)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2723536A1 (fr) * 1994-08-11 1996-02-16 Seth Pawan Composition permettant une liberation selective d'un principe actif
US5800422A (en) * 1995-06-02 1998-09-01 Alza Corporation Osmotic device with delayed activation of drug delivery and complete drug release
US5902605A (en) * 1996-04-18 1999-05-11 Alza Corporation Drug delivery device with minimal residual drug retention
AU7706598A (en) * 1997-05-30 1998-12-30 Laboratorios Phoenix U.S.A., Inc. Multi-layered osmotic device
US6186991B1 (en) 1998-06-29 2001-02-13 The Procter & Gamble Company Disposable article having a responsive system including a mechanical actuator
US7772455B1 (en) 1997-11-14 2010-08-10 The Procter & Gamble Company Disposable article providing improved management of bodily exudates
US6149636A (en) 1998-06-29 2000-11-21 The Procter & Gamble Company Disposable article having proactive sensors
US5916595A (en) * 1997-12-12 1999-06-29 Andrx Pharmaceutials, Inc. HMG co-reductase inhibitor
EP2138191A1 (en) 1998-01-05 2009-12-30 University Of Washington Enhanced transport using membrane disruptive agents
US6660301B1 (en) * 1998-03-06 2003-12-09 Biosphere Medical, Inc. Injectable microspheres for dermal augmentation and tissue bulking
US6433244B1 (en) 1998-06-29 2002-08-13 The Procter & Gamble Company Disposable treatment article having a responsive system
CZ20004852A3 (cs) 1998-06-29 2001-08-15 The Procter & Gamble Company Zařízení pro manipulaci a odstranění odpadních látek
US6372951B1 (en) 1998-06-29 2002-04-16 The Procter & Gamble Company Disposable article having sensor to detect impending elimination of bodily waste
JP4407868B2 (ja) 1998-06-29 2010-02-03 ザ プロクター アンド ギャンブル カンパニー 順向センサーを有する使い捨て製品
US6160198A (en) * 1998-06-29 2000-12-12 The Procter & Gamble Company Disposable article having a discontinuous responsive system
WO2000000148A1 (en) 1998-06-29 2000-01-06 The Procter & Gamble Company Disposable treatment article having a responsive system
ATE266991T1 (de) 1998-06-29 2004-06-15 Procter & Gamble Absorbierender wegwerfartikel mit einem reagierenden system mit einem elektrischen antrieb
US6359190B1 (en) 1998-06-29 2002-03-19 The Procter & Gamble Company Device for measuring the volume of a body cavity
US6342037B1 (en) 1998-06-29 2002-01-29 The Procter & Gamble Company Device having fecal component sensor
US6531152B1 (en) 1998-09-30 2003-03-11 Dexcel Pharma Technologies Ltd. Immediate release gastrointestinal drug delivery system
US6632451B2 (en) 1999-06-04 2003-10-14 Dexcel Pharma Technologies Ltd. Delayed total release two pulse gastrointestinal drug delivery system
GB9923045D0 (en) * 1999-09-29 1999-12-01 Novartis Ag New oral formulations
US7737108B1 (en) 2000-01-07 2010-06-15 University Of Washington Enhanced transport using membrane disruptive agents
WO2001070289A2 (en) 2000-03-20 2001-09-27 Biosphere Medical, Inc. Injectable and swellable microspheres for tissue bulking
NZ518216A (en) * 2000-08-09 2004-11-26 Panacea Biotec Ltd Pharmaceutical compositions of anti-tubercular drugs and process for their preparation
GB2369997B (en) * 2000-12-12 2004-08-11 Johnson & Johnson Medical Ltd Dressings for the treatment of exuding wounds
DE10100689A1 (de) * 2001-01-09 2002-07-18 Henkel Kgaa Wasch- und reinigungsaktive Substanzen enthaltende Mikrokapseln
US20030152622A1 (en) * 2001-10-25 2003-08-14 Jenny Louie-Helm Formulation of an erodible, gastric retentive oral diuretic
US20030091630A1 (en) * 2001-10-25 2003-05-15 Jenny Louie-Helm Formulation of an erodible, gastric retentive oral dosage form using in vitro disintegration test data
CA2409552A1 (en) 2001-10-25 2003-04-25 Depomed, Inc. Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract
US20030104052A1 (en) * 2001-10-25 2003-06-05 Bret Berner Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract
EP1530505A4 (en) * 2001-11-30 2007-09-12 Bristol Myers Squibb Co CONFIGURATIONS OF PIPETTES AND PIPETTE SETS FOR MEASURING CELLULAR ELECTRICAL PROPERTIES
DE10209979A1 (de) * 2002-03-07 2003-09-25 Ratiopharm Gmbh Arzneimittel mit Cholesterolspiegel-senkenden Wirkstoffen mit zeitverzögerter Wirkstofffreisetzung
US20040062778A1 (en) * 2002-09-26 2004-04-01 Adi Shefer Surface dissolution and/or bulk erosion controlled release compositions and devices
US7670627B2 (en) * 2002-12-09 2010-03-02 Salvona Ip Llc pH triggered targeted controlled release systems for the delivery of pharmaceutical active ingredients
US20040143221A1 (en) * 2002-12-27 2004-07-22 Shadduck John H. Biomedical implant for sustained agent release
TWI355276B (en) * 2003-01-14 2012-01-01 Akira Tsuji Gastrointestinal absorption enhancer mediated by p
US20060177507A1 (en) * 2003-05-22 2006-08-10 Joaquina Faour Controlled release device containing lercanidipine
US8029822B2 (en) * 2003-05-22 2011-10-04 Osmotica Kereskedelmi és Seolgáltató KFT Rupturing controlled release device having a preformed passageway
US20050139805A1 (en) * 2003-11-06 2005-06-30 Dale Koster Dechlorinating tablet and method of manufacture
US20040224019A1 (en) * 2004-03-03 2004-11-11 Adi Shefer Oral controlled release system for targeted drug delivery into the cell and its nucleus for gene therapy, DNA vaccination, and administration of gene based drugs
EP1737500A1 (en) * 2004-03-26 2007-01-03 The University of Utah Research Foundation Bioresponsive polymer system for delivery of microbicides
JP5199890B2 (ja) * 2006-02-28 2013-05-15 エフ．ホフマン−ラ ロシュ アーゲー 低溶解性化合物の吸収特性の評価法
WO2007109584A1 (en) * 2006-03-16 2007-09-27 University Of Washington Temperature-and ph-responsive polymer compositions
US8394415B2 (en) * 2006-11-21 2013-03-12 Mcneil-Ppc, Inc Modified release analgesic suspensions
US7981688B2 (en) 2007-03-08 2011-07-19 University Of Washington Stimuli-responsive magnetic nanoparticles and related methods
ES2393885T7 (es) 2007-06-04 2014-01-30 Synergy Pharmaceuticals Inc. Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
US9833510B2 (en) * 2007-06-12 2017-12-05 Johnson & Johnson Consumer Inc. Modified release solid or semi-solid dosage forms
US8349387B2 (en) * 2007-08-29 2013-01-08 Shionogi & Co., Ltd. Method for production of coated preparations
ES2522968T3 (es) 2008-06-04 2014-11-19 Synergy Pharmaceuticals Inc. Agonistas de guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos
AU2009270833B2 (en) 2008-07-16 2015-02-19 Bausch Health Ireland Limited Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
AU2009302818A1 (en) * 2008-10-10 2010-04-15 Alvine Pharmaceuticals, Inc. Dosage forms that facilitate rapid activation of zymogen
US8426214B2 (en) * 2009-06-12 2013-04-23 University Of Washington System and method for magnetically concentrating and detecting biomarkers
US8386031B2 (en) 2009-06-30 2013-02-26 Boston Scientific Scimed, Inc. Implantable self-powered biodegradable medical device to treat or prevent reperfusion injury
WO2011039686A1 (en) 2009-09-30 2011-04-07 Pfizer Inc. Latrepirdine oral sustained release dosage forms
US20110117668A1 (en) * 2009-11-09 2011-05-19 University Of Washington Through Its Center For Commercialization Self-powered smart diagnostic devices
US9080933B2 (en) 2009-11-09 2015-07-14 University Of Washington Through Its Center For Commercialization Stimuli-responsive polymer diagnostic assay comprising magnetic nanoparticles and capture conjugates
SG10201501027XA (en) 2010-02-10 2015-04-29 Univ Kingston Water with Switchable Ionic Strength
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
BR112013014972B1 (pt) 2010-12-15 2020-12-29 Queen's University At Kingston método para remover um soluto da solução aquosa ou para concentrar a solução aquosa diluida através da modulação da força iônica de uma solução aquosa
AU2014218599C1 (en) 2013-02-25 2018-09-06 Bausch Health Ireland Limited Guanylate cyclase receptor agonists for use in colonic cleansing
CA2905435A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
JP2016514671A (ja) 2013-03-15 2016-05-23 シナジー ファーマシューティカルズ インコーポレイテッド グアニル酸シクラーゼのアゴニストおよびその使用
JP6041823B2 (ja) 2013-03-16 2016-12-14 ファイザー・インク トファシチニブの経口持続放出剤形
EP3054969B1 (en) 2013-10-10 2021-03-10 Bausch Health Ireland Limited Agonists of guanylate cyclase useful for the treatment of opioid induced dysfunctions
US20160060589A1 (en) * 2014-09-01 2016-03-03 Abnova (Taiwan) Corporation Particle transporting system and method of operating the same
US20190307912A1 (en) * 2015-10-20 2019-10-10 Takasago International Corporation Fragrance delivery device, system, and method
JP6944822B2 (ja) * 2017-06-27 2021-10-06 持田製薬株式会社 易服用性カプセル
WO2021014360A1 (en) 2019-07-23 2021-01-28 Pfizer Inc. Oral modified release dosage forms
CN114727950A (zh) 2019-11-14 2022-07-08 辉瑞大药厂 1-(((2s,3s,4s)-3-乙基-4-氟-5-氧代吡咯烷-2-基)甲氧基)-7-甲氧基异喹啉-6-羧酰胺组合及口服剂型

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3247066A (en) * 1962-09-12 1966-04-19 Parke Davis & Co Controlled release dosage form containing water-swellable beadlet
US4177256A (en) * 1973-04-25 1979-12-04 Alza Corporation Osmotic bursting drug delivery device
US4135514A (en) * 1974-12-23 1979-01-23 Alza Corporation Osmotic releasing system for administering ophthalmic drug to eye of animal
US3952741A (en) * 1975-01-09 1976-04-27 Bend Research Inc. Controlled release delivery system by an osmotic bursting mechanism
US4016880A (en) * 1976-03-04 1977-04-12 Alza Corporation Osmotically driven active agent dispenser
FR2471186A1 (fr) * 1979-12-10 1981-06-19 Roussel Uclaf Nouveaux comprimes a delitescence colique, ainsi que leur procede de preparation
US4539199A (en) * 1981-01-14 1985-09-03 Egyt Gyogyszervegyeszeti Gyar Sustained release pharmaceutical compositions
US4522625A (en) * 1982-09-29 1985-06-11 Alza Corporation Drug dispenser comprising wall formed of semipermeable member and enteric member
DE3243710A1 (de) * 1982-11-25 1984-05-30 Delma, elektro- und medizinische Apparatebau GmbH, 7200 Tuttlingen Operationsleuchte
US4851231A (en) * 1982-12-13 1989-07-25 Alza Corporation System for delivering drug in selected environment of use
US4578075A (en) * 1982-12-20 1986-03-25 Alza Corporation Delivery system housing a plurality of delivery devices
US4773907A (en) * 1982-12-20 1988-09-27 Alza Corporation Primary delivery system comprising secondary dosage form
US4681583A (en) * 1982-12-20 1987-07-21 Alza Corporation System for dispersing drug in biological environment
US4503030A (en) * 1983-06-06 1985-03-05 Alza Corporation Device for delivering drug to certain pH environments
US4587117A (en) * 1983-06-06 1986-05-06 Alza Corporation Medical device for delivering drug to pH environments greater than 3.5
US4627850A (en) * 1983-11-02 1986-12-09 Alza Corporation Osmotic capsule
SE457505B (sv) * 1984-01-10 1989-01-09 Lejus Medical Ab Laminatbelagd oral farmaceutisk komposition och foerfarande foer dess framstaellning
US4627851A (en) * 1984-10-26 1986-12-09 Alza Corporation Colonic-therapeutic delivery system
US4693895A (en) * 1984-10-26 1987-09-15 Alza Corporation Colon delivery system
US4705515A (en) * 1984-10-26 1987-11-10 Alza Corporation Dosage form for administering drug of the colon
GB8518301D0 (en) * 1985-07-19 1985-08-29 Fujisawa Pharmaceutical Co Hydrodynamically explosive systems
IL77186A0 (en) * 1985-11-29 1986-04-29 Touitou Elka Pharmaceutical insulin composition
SE460945B (sv) * 1987-01-15 1989-12-11 Lejus Medical Ab En multipel-unit-dos komposition av furosemid
US4830855A (en) * 1987-11-13 1989-05-16 Landec Labs, Inc. Temperature-controlled active agent dispenser
US4904474A (en) * 1988-01-25 1990-02-27 Alza Corporation Delivery of drug to colon by oral disage form
US5472710A (en) * 1988-04-16 1995-12-05 Schwarz Pharma Ag Pharmaceutical preparation to be administered orally with controlled release of active substance and method for its manufacture
JP2792862B2 (ja) * 1988-07-30 1998-09-03 寛治 高田 経口腸溶製剤
IL91398A (en) * 1988-08-30 1994-05-30 Pfizer A device for the controlled release of pneumatic substances, including the active substance, surrounded by an asymmetric membrane
EP0408496A3 (en) * 1989-07-12 1992-07-01 Ciba-Geigy Ag Solid dosage form for pharmaceutical substances
US5178866A (en) * 1990-03-23 1993-01-12 Alza Corporation Dosage form for delivering drug to the intestine
WO1992011845A1 (en) * 1991-01-03 1992-07-23 Glaxo Canada Inc. Method for production of solid pharmaceutical preparation
US5443459A (en) * 1991-01-30 1995-08-22 Alza Corporation Osmotic device for delayed delivery of agent
NZ242065A (en) * 1991-03-26 1996-06-25 Csl Ltd Delayed release implant having a degradable or rupturable polymeric coating
US5364634A (en) * 1991-11-08 1994-11-15 Southwest Research Institute Controlled-release PH sensitive capsule and adhesive system and method

Also Published As

Publication number Publication date
IL108691A0 (en) 1994-05-30
FI940866A (fi) 1994-08-26
PT612520E (pt) 2001-12-28
NO940642D0 (no) 1994-02-24
NZ250967A (en) 1996-02-27
EP0612520A3 (en) 1995-11-15
ATE202927T1 (de) 2001-07-15
NO312123B1 (no) 2002-03-25
DK0612520T3 (da) 2001-09-17
DE69427664D1 (de) 2001-08-16
GR3036497T3 (en) 2001-11-30
FI113941B (fi) 2004-07-15
ES2157953T3 (es) 2001-09-01
CA2116288A1 (en) 1994-08-26
DE69427664T2 (de) 2001-10-25
JP2862222B2 (ja) 1999-03-03
AU5640094A (en) 1994-09-22
US5358502A (en) 1994-10-25
EP0612520A2 (en) 1994-08-31
EP0612520B1 (en) 2001-07-11
TW283641B (ja) 1996-08-21
CN1098286A (zh) 1995-02-08
FI940866A0 (fi) 1994-02-24
AU660386B2 (en) 1995-06-22
NO940642L (no) 1994-08-26
US5609590A (en) 1997-03-11
JPH072645A (ja) 1995-01-06
CA2116288C (en) 1997-11-18
MX9401396A (es) 1994-08-31

Similar Documents

Publication Publication Date Title
TW283641B (ja)
ATE133561T1 (de) Orale, osmotische vorrichtung
ATE196077T1 (de) Osmotische vorrichtung mit dampfdurchlaessiger beschichtung
IE860213L (en) Lipid osmotic pump
CA2316886A1 (en) Beneficial agent delivery system with membrane plug
LV12452A (lv) Aktivas vielas vaginala ievadisanas sistema
MY134742A (en) Delivery device having encapsulated excipients
CA2150019A1 (en) Supported Liquid Membrane Delivery Devices
IE882898L (en) Solubility modulated drug delivery device
IE851524L (en) Osmotically active system for dispensing drugs
IT1243717B (it) Compresse o capsule diserbanti per l'applicazione a risaie
DE69209083D1 (de) System zur peroralen arzneimittelabgabe
KR880005944A (ko) 삼투성 연속 분배 경구용 전달 시스템
JPS5519232A (en) Preparation of slow-releasing capsule containing physiologically active substance